The market keeps trying to put SMX (NASDAQ:SMX) in a box. Plastics. Metals. Electronics. Rubber. Fashion. Every time a new ...

Scientists from Turkey have designed a next-generation implantable biosensor using genetically engineered E. coli for ...

Countless bacterial species share cramped environments where competition for space and resources is fierce. Some rely on a ...

The SERENA-6 trial shows a 54% reduced risk of death with camizestrant, with a median PFS of 16.6 months versus 9.2 months ...

D Molecular Therapeutics ( ($FDMT) ) has shared an update. On December 10, 2025, 4D Molecular Therapeutics announced amendments to its Phase 3 ...

In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy ...

The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...

LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ("Molecular Partners" or the ...

As of Monday, December 08, Molecular Partners AG’s MOLN share price has dipped by 8.63%, which has investors questioning if this is right time to buy.

Researchers have identified a molecular mechanism that helps explain why growing up in a stimulating environment enhances ...

Triana Biomedicines has tapped Pfizer Ventures and a number of other existing and new investors to secure a $120 million ...

Researchers have used cryo-EM and computational tools to visualize ribozyme assembly, shedding light on life's most versatile ...